New RSV vaccine trial aims to protect older adults
⭐️ VACCINE ⭐️
Recruiting now
This study tests a new vaccine against respiratory syncytial virus (RSV) in adults. Phase I includes adults 18 and older to check safety, while Phase II focuses on adults 60 and older to see how well the vaccine triggers an immune response. The goal is to find a safe and effectiv…
Phase: PHASE1, PHASE2 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 16, 2026 12:54 UTC